Tuomas Heikkinen Selected Research

Eosine Yellowish-(YS) (Eosin)

1/2018

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tuomas Heikkinen Research Topics

Disease

26	Breast Neoplasms (Breast Cancer) 04/2015 - 12/2008
17	Neoplasms (Cancer) 02/2016 - 02/2006
5	Leiomyoma (Uterine Fibroids) 09/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 08/2013 - 07/2011
2	Carcinogenesis 08/2013 - 01/2011
2	Endometrial Neoplasms (Endometrial Cancer) 07/2010 - 02/2006
1	Adenomyoma 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Intellectual Disability (Idiocy) 02/2016
1	alpha-Thalassemia 02/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Fibroadenoma 01/2016
1	Hereditary leiomyomatosis and renal cell cancer 01/2016
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 10/2012
1	Ovarian Epithelial Carcinoma 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2011
1	Fanconi Anemia (Fanconi's Anemia) 04/2011
1	Oculocutaneous albinism type 2 05/2010

Drug/Important Bio-Agent (IBA)

13	Estrogen ReceptorsIBA 01/2014 - 05/2009
9	Proteins (Proteins, Gene)FDA Link 02/2016 - 02/2006
6	Progesterone Receptors (Progesterone Receptor)IBA 08/2013 - 05/2009
5	Estrogens (Estrogen)FDA Link 08/2013 - 05/2009
4	Genetic Markers (Genetic Marker)IBA 05/2013 - 09/2009
4	Hormones (Hormone)IBA 02/2011 - 05/2010
3	Formaldehyde (Formol)FDA Link 12/2020 - 09/2012
3	ParaffinIBA 12/2020 - 09/2012
3	Mediator ComplexIBA 01/2018 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 05/2010
2	Fumarate Hydratase (Fumarase)IBA 01/2018 - 01/2016
2	Nonsense Codon (Nonsense Mutation)IBA 01/2017 - 02/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 09/2009
2	MicroRNAs (MicroRNA)IBA 01/2014 - 06/2011
2	AnthracyclinesIBA 08/2013 - 09/2012
2	Keratins (Keratin)IBA 09/2012 - 05/2010
2	AndrogensIBA 04/2011 - 07/2010
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 09/2009
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2022
1	Cullin Proteins (Cullins)IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 12/2020
1	HMGA2 ProteinIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	X-linked Nuclear ProteinIBA 02/2016
1	Cyclin CIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2016
1	Leucine (L-Leucine)FDA Link 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2014
1	Eukaryotic Initiation Factor-4EIBA 08/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 08/2013
1	A-Form DNA (A-DNA)IBA 09/2012
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	P 11 (P-11)IBA 09/2012
1	human ERBB2 proteinIBA 12/2011
1	GlycodelinIBA 07/2011
1	Tumor Biomarkers (Tumor Markers)IBA 02/2011
1	P-2 (P 2)IBA 02/2011
1	Cyclin EIBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 05/2010
1	Epidermal Growth Factor (EGF)IBA 05/2010
1	OligonucleotidesIBA 05/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2010
1	Carrier Proteins (Binding Protein)IBA 09/2009
1	ORALIT (ORS)IBA 05/2009

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2015 - 09/2012
3	Therapeutics 05/2013 - 05/2010
2	Adjuvant Chemotherapy 04/2015 - 08/2013
1	Radiotherapy 10/2013
1	Palliative Care (Palliative Therapy) 09/2012